Quest Diagnostics Incorporated (LON:0KSX)
210.18
+2.18 (1.05%)
Feb 12, 2026, 5:06 PM GMT
Quest Diagnostics Revenue
In the year 2025, Quest Diagnostics had annual revenue of $11.04B USD with 11.78% growth. Quest Diagnostics had revenue of $2.81B in the quarter ending December 31, 2025, with 7.06% growth.
Revenue
$11.04B
Revenue Growth
+11.78%
P/S Ratio
2.06
Revenue / Employee
$193.60K
Employees
57,000
Market Cap
16.88B GBP
Revenue Chart
* This company reports financials in USD.
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 11.04B | 1.16B | 11.78% |
| Dec 31, 2024 | 9.87B | 620.00M | 6.70% |
| Dec 31, 2023 | 9.25B | -631.00M | -6.38% |
| Dec 31, 2022 | 9.88B | -905.00M | -8.39% |
| Dec 31, 2021 | 10.79B | 1.35B | 14.32% |
| Dec 31, 2020 | 9.44B | 1.71B | 22.15% |
| Dec 31, 2019 | 7.73B | 195.00M | 2.59% |
| Dec 31, 2018 | 7.53B | 129.00M | 1.74% |
| Dec 31, 2017 | 7.40B | 188.00M | 2.61% |
| Dec 31, 2016 | 7.21B | -279.00M | -3.72% |
| Dec 31, 2015 | 7.49B | 58.00M | 0.78% |
| Dec 31, 2014 | 7.44B | 289.00M | 4.04% |
| Dec 31, 2013 | 7.15B | -237.00M | -3.21% |
| Dec 31, 2012 | 7.38B | -9.00M | -0.12% |
| Dec 31, 2011 | 7.39B | 131.88M | 1.82% |
| Dec 31, 2010 | 7.26B | -195.12M | -2.62% |
| Dec 31, 2009 | 7.46B | 205.80M | 2.84% |
| Dec 31, 2008 | 7.25B | 544.54M | 8.12% |
| Dec 31, 2007 | 6.70B | 436.25M | 6.96% |
| Dec 31, 2006 | 6.27B | 811.93M | 14.88% |
| Dec 31, 2005 | 5.46B | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| AstraZeneca | 43.24B |
| GSK plc | 32.67B |
| Haleon | 11.02B |
| Smith & Nephew | 4.33B |
| Hikma Pharmaceuticals | 2.35B |
| Convatec Group | 1.72B |
| CVS Group | 673.20M |
| Genus | 672.80M |
Quest Diagnostics News
- 1 day ago - Quest Diagnostics (DGX): Truist Securities Raises Price Target Amidst Hold Rating | DGX Stock News - GuruFocus
- 1 day ago - UBS Raises Price Target for Quest Diagnostics (DGX) to $210 | DGX Stock News - GuruFocus
- 1 day ago - DGX: Evercore ISI Group Raises Price Target for Quest Diagnostics | DGX Stock News - GuruFocus
- 1 day ago - Goldman Sachs MarketBeta U.S. Equity ETF Buys 207 Shares of Quest Diagnostics Inc (DGX) - GuruFocus
- 1 day ago - DGX: Jefferies Raises Target Price for Quest Diagnostics to $220 | DGX Stock News - GuruFocus
- 1 day ago - DGX Crosses Above Average Analyst Target - Nasdaq
- 1 day ago - Quest Diagnostics Shares Jump on Q4 Beat; FY25 Revenue Rises, 2026 Outlook Raised - AlphaStreet
- 2 days ago - Quest Diagnostics Inc (DGX) Q4 2025 Earnings Call Highlights: Strong Revenue Growth and ... - GuruFocus